GLYCOPROTEINHORMONREZEPTORMUTATIONEN
European patent · EP3155011 · In force
Register entry
- Publication number
- EP3155011
- Application number
- EP15738404
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 11, 2015
- Published
- Apr 19, 2017
- Granted
- Nov 10, 2021
- Protection ends at the latest
- Jun 10, 2035
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C07K 14/72 (2006.01)C12N 15/01 (2006.01)
- Priority
- GB 201410409 11.06.2014
- PCT application
- PCT/GB2015/000171 11.06.2015
- PCT publication
- WO2015/189543 17.12.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 15, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 15.07.2026
- Jul 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
- Jul 1, 2024
Change
Published in Swissreg on 01.07.2024
- Jul 1, 2023
Change
Published in Swissreg on 01.07.2023
- Sep 21, 2022
Change
Published in Swissreg on 21.09.2022
- Jul 1, 2022
Change
Published in Swissreg on 01.07.2022
- Nov 29, 2021
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 29.11.2021
- Nov 10, 2021
Granted
Published in Swissreg on 10.11.2021
Parties
Inventor
Cardiff South Wales CF14 9HX, GB
Vale of Glamorgan CF62 3AT, GB
Cardiff South Wales CF14 7DD, GB
Cardiff South Wales CF3 6XD, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.